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 25 
Short version of title: Prognosis of co-twin in single intrauterine fetal death 26 
 27 
Abstract 28 
Background: Single intrauterine fetal death affects approximately 6% of twin 29 
pregnancies and can have serious sequelae for the surviving co-twin. 30 
Objectives: Determine the prognosis of the surviving co-twin following spontaneous 31 
single intrauterine fetal deathIUFDs to aid counselling patients and highlight areas of 32 
future research areas. 33 
Search strategy: Medline, Embase, Web of Science, and Cochrane Library, from 34 
1980 and June 2017. 35 
Selection criteria: Studies of ≥5 cases of spontaneous single intrauterine fetal 36 
death after 14 weeks gestation, in diamniotic twin pregnancies.  37 
Data collection and analysis: Summary event rates were calculated and stratified 38 
by chorionicity. Monochorionic and dichorionic twins, and sub-groups, were 39 
compared by odds ratios.  40 
Main results: In monochorionic twins, when single intrauterine fetal death occurred 41 
at <28 weeks gestation, this significantly increased the rate of co-twin intrauterine 42 
fetal death (OR 2.31[95%CI 1.02, 5.25],I2=0.0%,12 studies,184 pregnancies) and 43 
neonatal death (OR 2.84[95%CI1.18,6.77],I2=0.0%,10 studies,117 pregnancies) 44 
compared to when the single intrauterine fetal deathIUFDs occurred >28 weeks. 45 
Neonatal death in monochorionic twins was significantly higher if the pregnancy was 46 
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complicated by fetalintrauterine growth restriction (OR 47 
4.83[95%CI1.14,20.47],I2=0.0%,6 studies,60 pregnancies) or preterm birth (OR 48 
4.95[95%CI 1.71,14.30],I2=0.0%,11 studies,124 pregnancies). Abnormal antenatal 49 
brain imaging was reported in 20.0% ([95%CI12.8,31.1]I2=21.9%,6 studies,116 50 
pregnancies) of surviving monochorionic co-twins. The studies included in this meta-51 
analysis demonstrated small study effects and possible selection bias. 52 
Conclusions: Preterm birth was the commonest adverse outcome affecting 58.5% 53 
and 53.7% of monochorionic and dichorionic twin pregnancies and was associated 54 
with increased neonatal death risk. The studies included in this meta-analysis 55 
demonstrated small study effects and possible selection bias. Outcomes regarding 56 
brain imaging and neurodevelopmental comorbidity are an important area for future 57 
research but meta-analysis was limited due to different methods of assessment. 58 
 59 
Funding: FLM is funded by the Richard and Jack Wiseman Trust but they had no 60 
involvement in study design; in the collection, analysis and interpretation of the data; 61 
in the writing of the report; and in the decision to submit the article for publication. 62 
 63 
Keywords: co-twin death, fetal brain imaging, fetalintrauterine growth restriction, 64 
neonatal death, neurodevelopmental comorbidity, preterm birth, prognosis, single 65 
intrauterine fetal death, twin pregnancy, twin-twin transfusion syndrome 66 
 67 
Tweetable abstract: Preterm birth highest risk in single #twin death. Abnormal 68 
antenatal brain imaging in 1/5 surviving MC twins. 69 
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Introduction 70 
Twin pregnancies are associated with increased perinatal morbidity and mortality 71 
compared to singletons.  Single intrauterine fetal death (sIUFD) occurs in 72 
approximately 6% of twin pregnancies, making it a common adverse event (1). 73 
Monochorionic (MC) twins with placental inter-twin anastomoses conjoining the fetal 74 
circulations are associated with an increased risk of sIUFD and consequential fetal 75 
morbidity (2, 3). Many are first trimester fetal losses, but sIUFD after 14 weeks 76 
gestation is associated with greatest adverse effect on the surviving fetus (4). Morbid 77 
events associated with sIUFD in twin pregnancy include: co-twin IUFD, preterm birth 78 
(spontaneous or iatrogenic), and long term comorbidity; most commonly ante- or 79 
postnatal brain injury. A critical appraisal and interpretation of the literature is 80 
complicated by significant heterogeneity in the incidence and management in 81 
reported studies (5). In 2011, our group completed a systematic review and meta-82 
analysis of co-twin prognosis following sIUFD, with outcomes stratified by 83 
chorionicity. In the 22 included manuscripts there were 343 cases of sIUFD reported 84 
in 6225 twin pregnancies (6). A meta-analysis of event rates was not undertaken as 85 
there was a high risk of heterogeneity and low number of events within each study. A 86 
summary point estimate was produced with a simple binomial confidence interval, 87 
thus not allowing for the non-independence of the different studies. This manuscript 88 
demonstrated an increased odds ratio of co-twin death and neurodevelopmental 89 
morbidity after sIUFD in MC compared to dichorionic (DC) twin pregnancies. The 90 
management of multiple pregnancies in general, particularlyand MC pregnancies in 91 
particular, has received considerable attention since 2011 with national and 92 
international guidelines being published by international professional bodies (7-12). 93 
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Importantly the 2011 review included twin pregnancies that had undergone 94 
intervention for twin-twin transfusion syndrome (TTTS) and fetal growth restriction 95 
(FGR) IUGR, thus confounding factors such as surgeon experience may have will 96 
affected the reported prognosis (13). This review will focus on spontaneous sIUFD 97 
only and will not include pregnancies that have undergone treatment for TTTSFLA or 98 
IUGRFGR. 99 
 100 
The objective of the study wais to determine the prognosis of the surviving co-twin 101 
following spontaneous sIUFD. The outcomes explored wwereill be: co-twin IUFD, 102 
preterm birthPTB, abnormal postnatal brain imaging and neurodevelopmental 103 
comorbidity as analysed in our previous systematic review and meta-analysis, and 104 
the additional outcomes of abnormal antenatal brain imaging and neonatal death 105 
wwereill also be examined. This review haswill allow allowed inclusion of the recent 106 
literature informing clinical practice to aid counselling patients and highlight areas of 107 
future research. 108 
 109 
Methods 110 
The systematic review was performed according to an a priori protocol and complied 111 
with recommended guidance including the ‘Meta-analyses and systematic reviews 112 
Of Observational Studies’ (MOOSE) and ‘Preferred Reporting Items for Systematic 113 
reviews and Meta-Analyses’ (PRISMA) guidelines (14, 15). Ethical approval was not 114 
required. FLM is funded by the Richard and Jack Wiseman Trust but they had no 115 
involvement in study 116 
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Eligibility criteria 117 
Studies must have included at least 5 cases of sIUFD in twin pregnancies, and the 118 
gestation of the initial sIUFD must have been after 14 weeks. Twin chorionicity had 119 
to be defined but studies did not have to include both MC and DC twin pregnancies 120 
in the same study. Studies were excluded if the following conditions could not be 121 
abstracted for analysisremoved for analysis i.e. if the following cases were not 122 
identifiable in analysis: selective termination, higher order multiple pregnancies, twin 123 
reversed arterial perfusion (TRAP) sequence, structural or chromosomal anomalies, 124 
conjoined twins, monoamniotic twins, or first-trimester miscarriages associated with 125 
twins. As the aim of the study was to assess spontaneous IUFD, IUFDs which 126 
occurred following an intervention for TTTS or sIUGRFGR, including fetoscopic laser 127 
ablation (FLA) or bilateral cord occlusion (BCO), were not included in the analysis as 128 
there are confounding factors that may affect the outcome of the pregnancy, 129 
including surgeon experience, which make this group heterogeneous (13). As FLA 130 
dichorionises the placenta and this was considered to have more of an effect on 131 
outcome, whereas aAmniodrainagemniodrainage was not considered an intervention 132 
thatwhich affects would affect co-twinthe prognosis in the co-twin, as the main 133 
reason for IUFD following amniodrainage is likely due to TTTS itself, rather than a 134 
complication of the amniodrainageprocedure, thus these pregnancies remained in 135 
the analysis.  136 
Outcomes 137 
There is no core outcome set for multiple pregnancy, particularly sIUFD co-twin 138 
survivors, and patients were not involved in the development of the research, thus 139 
the outcomes assessed were the outcomes in the previous review, with the addition 140 
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of antenatal brain imaging and neonatal death. The outcomes were defined a priori 141 
as: 142 
• Co-twin intrauterine fetal death, >14 weeks gestation but prior to delivery. 143 
• Preterm birth (PTB), defined as a live birth of the surviving co-twin, 144 
irrespective of whether the birth was spontaneous or iatrogenic which will be 145 
explored as a sub-group analysis, between 24+0-34+0 weeks gestation as 146 
some monochorionic diamniotic MCDA twins are routinely delivered at <36 147 
weeks, and with little long-term consequence.  148 
• Abnormal antenatal brain imaging. There was no limit on timing of imaging 149 
post-IUFD or type of imaging due to no consensus guidance existing at the 150 
time of this review. 151 
• Abnormal postnatal brain imaging. There was no limit on imaging modality. . 152 
• Neurodevelopmental comorbidity, defined as per study, as there is no 153 
standard test to assess this in sIUFD. 154 
• Neonatal death (NND), defined as death within 28 days of live birth. 155 
 156 
Information sources 157 
The search was performed according to previously published methods (6). In brief, 158 
Medline, Embase, Web of Science, Cochrane Library and British Nursing Index were 159 
searched. Due to including the new outcomes of abnormal antenatal brain imaging, 160 
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and neonatal death, the information searches were run from 1980 due to the 161 
introduction of ultrasound into clinical practice, to 9th June 2017.  162 
 163 
Search strategy 164 
Keywords and variants of “intrauterine” “death” and “twin” were used (see Appendix 165 
S1 for search strategy). Bibliographies were manually checked and there was no 166 
restriction on language.  167 
 168 
Study selection and data extraction 169 
FLM, AR and RKM independently extracted the data needed to assess the quality of 170 
the studies and form a 2x2 contingency table, using piloted data collection forms. 171 
Data from the previous systematic review by Hillman (6) was re-extracted by FLM 172 
and RKM. Any discrepancies were resolved by MDK. If clarification was required 173 
authors were contacted. 174 
 175 
Quality assessment of included studies 176 
The quality of the studies was assessed according to the ‘Strengthening the 177 
Reporting of Observational studies in Epidemiology’ (STROBE) checklist (16). 178 
 179 
Assessment of heterogeneity 180 
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Heterogeneity between the studies was assessed visually using forest plots and 181 
statistically using the I2 statistic. An I2 statistic ≥50% indicated a high-risk of 182 
heterogeneity. Heterogeneity was investigated via sub-group and sensitivity analysis. 183 
 184 
Assessment of reporting bias 185 
If >10 studies were included in a meta-analysis, a funnel plot was generatedusing 186 
the metafunnel command (17)  in Stata (Stata, 2015 Release 13.1, StataCorp. 187 
Texas, USA) and Egger’s test was performed using the metabias command (18), 188 
with p<0.05 considered a significant risk of small-study effects publication bias. 189 
 190 
Data synthesis 191 
With the additional 20 studies, we have produced a summary event rate statistic 192 
which has allowed for the non-independence of different studies when the data is 193 
pooled, as is appropriate in a meta-analysis. This was calculated using the metan 194 
command (1).Odds ratios (ORs) with random effects were calculated to compare the 195 
risk in MC twin pregnancies with DC twin pregnancies using the metan command. 196 
0.5 was added to 0 cells in all analyses to allow inclusion of more studies (20).(17). If 197 
a study only included MC twin pregnancies, the study was used to calculate the 198 
summary event rate for MC twins only, and was not included in the DC summary 199 
event rate or OR calculation of MC vs. DC twins, and vice versa if a study only 200 
included DC twin pregnancies. Sub-group analysis, in analyses of ≥3 studies, was 201 
planned to evaluate the effect of factors identified as potential causes of 202 
heterogeneity prior to commencing analysis: gestational age of sIUFD <28 weeks, 203 
TTTS (managed conservatively meaning no intervention but continued surveillance), 204 
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IUGRFGR (managed conservatively), year of publication pre-and post-2011. Twenty-205 
eight weeks was chosen as a cut-off to distinguish between trimesters as there is no 206 
research to determine an evidence-based cut-off. PTB as an outcome was also 207 
divided by iatrogenic and spontaneous where possible. Antenatal and postnatal brain 208 
imaging were divided by imaging modality, and the postnatal outcomes were also 209 
divided by PTB where possible, the latter irrespective of whether the PTB was 210 
iatrogenic or spontaneous. The sub-group summary event rate was reported as the 211 
rate of the outcome (e.g. co-twin IUFD) in women with or without that factor (e.g. 212 
sIUFD at <28 weeks, TTTS, IUGRFGR) to enable maximum clinical utility for 213 
counselling women in each scenario. ORs were calculated to compare the summary 214 
event rate for each factor in MC and DC twin pregnancies. 215 
 216 
Results 217 
Study selection and characteristics 218 
The search revealed 2966 citations potentially eligible for inclusion, of which 2629 219 
were excluded on the title or abstract, 337 complete manuscriptsfull papers were 220 
assessed, and 42 full papers were eligible for inclusion (2, 3, 18-57) (Figure S1). The 221 
characteristics of the included studies are described in Supplementary File Table S1 222 
which summarises the study design, study population, and details of abnormal brain 223 
imaging and neurodevelopmental comorbidity. The previous review included 22 224 
studies (2, 19, 20, 22, 26, 28, 30, 32, 34, 35, 37, 41-43, 47, 49, 50, 52, 54, 55, 57, 225 
58). Of the 42 studies, 39 were included in the meta-analysis (for details of excluded 226 
studies and Appendix S2). The additional outcomes of antenatal brain imaging and 227 
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neonatal death were reported by 6 studies, and 19 studies respectively. The imaging 228 
modalities used were ultrasound and fetal magnetic resonance imaging (fMRI) 229 
antenatally, and CT scan was also used postnatally.  230 
 231 
Risk of bias of included studies 232 
The quality of the included studies is displayed in Figure 1. All the studies reported 233 
study design and the number of outcome events. None of the studies explained how 234 
their sample size was determined. The number of participants at each stage of the 235 
study was reported in 20/42 (47.6%) studies which may be that selective reporting 236 
occurred in some studies. Only 15/42 (35.7%) studies reported which data were 237 
missing, and 19/42 (45.2%) adequately reported the limitations of their study. When 238 
there were >10 studies and Egger’s test was performed, the results were reported 239 
below with each outcome as some analyses did suggest small-study effects 240 
publication bias. 241 
 242 
**Figure 1 about here please** 243 
 244 
Synthesis of results 245 
Summary event rates 246 
 247 
**Table 1 about here please** 248 
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 249 
The co-twin survivor in MC twin pregnancies was at significantly higher risk of co-250 
twin IUFD (Table 1, Figure 2. Additional forest plots and extracted 2x2 data are 251 
shown in Appendix S3. 252 
) and abnormal postnatal brain imaging than co-twin survivors in DC twin 253 
pregnancies. No significant difference was found between MC and DC twin 254 
pregnancies in the rate of PTB, neurodevelopmental comorbidity or NND, although 255 
the latter outcome was borderline significant. The rate of abnormal antenatal brain 256 
imaging in MC twin pregnancies was 20%, but as no studies were found reporting 257 
this outcome in DC twin pregnancies, the OR was not calculated. The abnormal 258 
brain imaging findings included: intraventricular haemorrhage, periventricular 259 
haemorrhage, focal infarction, extensive encephalomalacia, poor sulcation and 260 
abnormal cortex consistent with extensive reparative polymicrogyria.  261 
Additional forest plots and extracted 2x2 data are shown in Appendix S3. 262 
 263 
**Figure 2 about here please** 264 
 265 
Sub-group  266 
Sub-group analysis demonstrated that in MC twin pregnancies, those with anthe 267 
sIUFD <28 weeks were significantly more likely to have a co-twin IUFD than those 268 
with anthe sIUFD ≥28 weeks. The pathologies of TTTS and IUGRFGR were not 269 
associated with an increased risk of co-twin IUFD (Table 2). Pregnancies 270 
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complicated by TTTS were significantly more likely to have a PTB than twin 271 
pregnancies without TTTS. When preterm birth was divided according to whether it 272 
was iatrogenic or spontaneous, in MC twins the summary event rate of iatrogenic 273 
PTB was 60.4% ([95%CI 33.5, 109.1] I2=0.00%, 3 studies, 7 pregnancies) compared 274 
to a spontaneous PTB rate of 37.1% % ([95%CI 20.5, 66.9] I2=24.1%, 3 studies, 4 275 
pregnancies). There were no significant sub-group results for abnormal postnatal 276 
brain imaging, or neurodevelopmental comorbidity in MC twins, and it was not 277 
possible to perform sub-group analysis for the abnormal antenatal brain imaging, as 278 
often this information was not included in the primary full manuscripts.  In DC twins 279 
the summary event rate of iatrogenic PTB was 32.4% ([95%CI 14.6, 72.1] I2=32.7%, 280 
3 studies, 6 pregnancies) compared to a spontaneous PTB rate of 70.7% ([95%CI 281 
31.8, 157.4] I2=0.0%, 3 studies, 6 pregnancies), although the wide 95% CIs should 282 
be noted, which may be due to small sample size.. Other sub-group analysis in DC 283 
twins was limited due to small numbers, but the following analyses were possible, 284 
none of which found a significant difference: sIUFD <28 weeks did not affect co-twin 285 
IUFD, PTB, abnormal postnatal brain imaging, neurodevelopmental comorbidity or 286 
NND; IUGRFGR did not affect co-twin IUFD or PTB, neurodevelopmental 287 
comorbidity or NND; PTB did not affect abnormal postnatal brain imaging, 288 
neurodevelopmental comorbidity or NND.  289 
 290 
**Table 2 about here please** 291 
 292 
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All six MC twin pregnancy studies which reported antenatal brain imaging compared 293 
fMRI with fetal ultrasound in the same pregnancy (18, 26, 29, 38, 46, 48). Ultrasound 294 
“missed” 6/19 (31.5%) lesions detected on fMRI in 3 studies (29, 38, 46) and the 295 
other 3 studies demonstrated concordance between the two imaging modalities (18, 296 
26, 48), although this difference was not statistically significant. In abnormal 297 
postnatal brain imaging, it was not possible to perform sub-group analysis based on 298 
the imaging modalities of MRI or CT scan as 2 studies used ultrasound and MRI (43, 299 
48), 1 study used ultrasound and CT (32), and 2 studies did not state the mode of 300 
imaging (31, 44). The rate of NND was higher in MC twin pregnancies where the 301 
initial sIUFD occurred <28 weeks gestation, in those with IUGRFGR, and those with 302 
a PTB. No factors affected the risk of adverse outcome in DC twin survivors. It was 303 
not possible to calculate ORs for the year of publication sub-group analysis. 304 
 305 
Publication bias 306 
The funnel plots for co-twin IUFD, PTB, abnormal postnatal brain imaging and 307 
neurodevelopmental comorbidity appear asymmetrical, and Egger’s test suggests 308 
small-study effects such as  publication bias may exist in MC and the DC twins 309 
(funnel plots available from authors on request).  310 
 311 
Discussion 312 
Main findings 313 
Abnormal antenatal brain imaging following sIUFD has not previously been meta-314 
analysed; we report a rate of 1 in 5 surviving MC co-twins demonstrating abnormal 315 
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brain imaging, which doubled on postnatal brain imaging. NND was another novel 316 
outcome in our review; we report a rate of almost 3 in 10 liveborn surviving MC co-317 
twins die in the neonatal periodresulting in a NND, and 2 in 10 DC co-twins. In MC 318 
twins, if the initial sIUFD occurred at <28 weeks gestation, this significantly increased 319 
the rate of co-twin IUFD and NND compared to pregnancies in which the initial 320 
sIUFD occurred >28 weeks. The presence of TTTS was associated with a significant 321 
increase in the rate of PTB, but no other adverse outcome.  322 
 323 
Strength and limitations 324 
This rigorous and robust systematic review provides clinicians and parents with the 325 
most up to date rates of complications in the surviving twin following spontaneous 326 
sIUFD as reported by the literature. It also allows more tailored counselling, for 327 
example, depending on the gestation of the initial sIUFD. According to international 328 
guidance (7-12), MC twins should be scanned at a minimum frequency of every 2 329 
weeks, and DC twins every 4 weeks, therefore it is possible that some cases of co-330 
twin IUFD have been missed by studies as there may appear to be a double IUFD at 331 
the subsequent ultrasound scan, although the surviving co-twin may have been alive 332 
for a substantial period following the initial sIUFD. Some of the sub-group analysis 333 
was limited because these data were not reported by the included studies. For 334 
example it was not possible to perform the sub-group analysis based on year of 335 
publication, thus the inclusion of older studies with different antenatal care guidance 336 
and neonatal care provision may increase the risk of heterogeneity. Ideally for the 337 
PTB outcome we would have performed further analysis using cut-offs of 24-28, 28-338 
32 weeks etc. as our definition of <34 weeks was somewhat crude, however there 339 
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were insufficient numbers of pregnancies to do this. It would also be more clinically 340 
useful if the gestation of sIUFD could be more specific than before or after 28 weeks, 341 
but this would require individual patient data. There was a myriad of differences 342 
between studies reporting brain imaging findings, including different referral criteria, 343 
different timing of antenatal imaging varying from 0-12 weeks post IUFD, different 344 
imaging modalities, antenatal imaging findings were rarely linked to postnatal 345 
imaging findings and neurodevelopmental comorbidity, follow-up was poor and no 346 
studies were found reporting antenatal brain imagining in DC twins. Different 347 
methods of assessing neurodevelopment were used, making interpretation difficult. 348 
The results of this meta-analysis are not applicable to women in low-income 349 
countries as most studies include populations from developed countries. 350 
 351 
Interpretation 352 
When co-twin IUFD is viewed in the context of the summary event rates, the rate 353 
appears higher in both MC and DC twins compared to our previous review. We 354 
advise caution when interpreting this result as it is possibly an overestimate. This 355 
may be because of the existence of small-study effects, such as  publication bias in 356 
this outcome, and it is likely that there is selectionve bias as authors are more likely 357 
to report adverse outcomes than normal outcomes. Nevertheless, these event rates 358 
are the most recent data available and 10 additional studies have been published 359 
since the previous review. The smaller 95%CI when comparing co-twin IUFD 360 
between chorionicities suggests that the most recent results are more realistic, and 361 
the increased rate seen in MC twins compared to DC twins is to be expected given 362 
the presence of vascular anastomoses in the former. The significant difference may 363 
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also be a consequence of an improved ability to determine chorionicity, better 364 
knowledge, and changes in monitoring over time. The lack of difference in adverse 365 
outcome, including co-twin IUFD, in TTTS pregnancies may be because of excluding 366 
TTTS pregnancies undergoing FLA or BCO, thus there was a higher proportion of 367 
milder cases of TTTS. This was different to the previous review but as the treatment 368 
for TTTS has advanced dramatically, and its use  is more widespread since 2011, 369 
and there are different confounding factors compared to in spontaneous sIUFD, it 370 
was important to include this restriction. TTTS was associated with an increased 371 
PTB rate, although it was not possible to determine if theyin these cases the PTBs 372 
were spontaneous or iatrogenic. No difference was found in PTB between MC and 373 
DC surviving co-twins, suggesting that the mechanism of PTB in these cases is not 374 
inherent to chorionicity or vascular anastomoses, but to factors common to all twin 375 
pregnancies. With regards to abnormal antenatal and postnatal brain imaging, these 376 
results are difficult to interpret for reasons previously outlined. The higher rate of 377 
abnormal postnatal brain imaging in MC twins compared to DC twins was expected 378 
as it is believed that when one MC twin dies, acute transfusional events through 379 
inter-twin placental anastomoses occur as reviewed by (as reviewed by Mackie et al. 380 
62)(59) resulting in cerebral injury detectable on postnatal brain imaging in the 381 
surviving co-twin. Whereas in DC twins the cause of the cerebral pathology is more 382 
likely a result of the pathological condition which killed the other twin, rather than a 383 
consequence of the sIUFD. The similarity between chorionicities and sub-group 384 
analysis in the neurodevelopmental comorbidity outcome may be due to small study 385 
size, or be a reflection of there being no difference in PTB between the 386 
chorionicities.. The borderline-significantly higher rate of NND in MC twins compared 387 
to DC twins was to be expected, particularly as if the initial sIUFD was <28 weeks, or 388 
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IUGRFGR or PTB was involved, the rate of NND was significantly higher in MC 389 
twins. It would be interesting to explore the relationship between these factors 390 
further, but it was not possible. 391 
 392 
Conclusion 393 
Our results will help clinicians counsel parents with a sIUFD and give information 394 
based upon chorionicity. The high rate of adverse outcomes highlights the 395 
importance of close antenatal surveillance, particularly in MC surviving co-twins, and 396 
those in which the sIUFD has occurred at <28 weeks. PTB was the commonest 397 
adverse outcome and clinicians and parents should be aware of the high risk of PTB 398 
in these pregnancies, and the potential requirement of neonatal unit admission. 399 
Outcomes regarding brain imaging and neurodevelopmental comorbidity are an 400 
important area for future research as this outcome is important to parents and will 401 
affect the quality of life of not only the surviving twin, but also other family members. 402 
The high rate of 20% of co-twins with an abnormal antenatal fMRI highlights that 403 
parents should always be offered antenatal brain imaging. In line with our findings, 404 
and those of the MERIDIAN study, the imaging modality should be fMRI not 405 
ultrasound(60). A study is needed examining antenatal and postnatal brain imaging 406 
and neurodevelopmental comorbidity in the same surviving co-twins, in a 407 
standardised manner, with adequate follow-up. The studies included in this meta-408 
analysis were small and small study effects were shown to exist, consequently the 409 
authors have recognised the need to perform a large population-based study and are 410 
in the process of conducting a study using data from the UK Obstetric Surveillance 411 
Survey (UKOSS). This will be the largest study of complications in the surviving co-412 
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twin in a population cared for using the same national guidance (for further details 413 
see (61)).  414 
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 642 
Table 1 Summary event rates and odds ratio of adverse outcome in surviving 
co-twin following single intrauterine fetal death in monochorionic (MC) and 
dichorionic (DC) twin pregnancies  
Adverse 
outcome in 
co-twin 
Monochorionic  
event rate 
Dichorionic  
event rate 
Odds ratio [95%CI] 
comparing MC v DC 
Co-twin intra-
uterine fetal 
death 
41.0% [95%CI 33.7, 
49.9] I2=44.2%, 32 
studies, 379 
pregnancies 
22.4% [95%CI 16.2, 
30.9] I2=21.7%, 20 
studies, 255 
pregnancies 
2.06 [95%CI 1.14, 
3.71] p=0.016, 
I2=0.0%, 19 studies, 
441 pregnancies 
Preterm birth 58.5% [95%CI 48.2, 
70.9] I2=11.7%, 20 
studies, 202 
pregnancies 
53.7% [95%CI 40.8, 
70.6] I2=0.0%, 12 
studies, 107 
pregnancies 
1.42 [95%CI 0.67, 
2.99] p=0.356, I2=1.5%, 
10 studies, 167 
pregnancies 
Abnormal 
antenatal 
brain fMRI  
20.0% [95%CI 12.8, 
31.1] I2=21.9%, 6 
studies, 116 
pregnancies 
 
NP 
 
NP 
Abnormal 
postnatal 
brain imaging 
43.0% [95%CI 32.8, 
56.3] I2=12.4%, 12 
studies, 140 
pregnancies 
21.2% [95%CI 10.6, 
42.4] I2=0.7%, 7 
studies, 75 
pregnancies 
5.41 [95%CI 1.03, 
28.58] p=0.047, 
I2=45.8%, 7 studies, 
142 pregnancies 
Neuro-
developmental 
comorbidity 
28.5% [95%CI 19.0, 
42.7] I2=0.0%, 13 
studies, 103 
pregnancies 
10% [95%CI 3.9, 
27.7] I2=0.0%, 8 
studies, 62 
pregnancies 
3.06 [95%CI 0.88, 
10.61] p=0.08, I2=0.0%, 
8 studies, 129 
pregnancies 
Neonatal 
death 
27.9% [95%CI 21.1, 
36.9] I2=0.0%, 18 
studies, 206 
pregnancies 
21.2% [95%CI 14.5, 
31.2] I2=0.0%, 12 
studies, 130 
pregnancies 
1.95 [95%CI 1.00, 
3.79] p=0.051, I2=0.0%, 
11 studies, 232 
pregnancies 
fMRI: fetal magnetic resonance imaging, NP: not possible to calculate. p value in the 
OR column denotes the significance of OR=1. 
 
Table 2 Significant results for sub-group analysis of adverse outcomes in surviving co-twin following single intrauterine fetal death 
in monochorionic twin pregnancies  
Adverse 
outcome in co-
twin 
GA of sIUFD <28 weeks TTTS IUGRFGR Preterm birth versus no preterm birth 
Co-twin intra-
uterine fetal 
death 
60.6% ([95%CI 45.8, 80.2] 
I2=30.4%, 14 studies, 114 
pregnancies) 
29.6% ([95%CI 19.2, 45.6] 
I2=0.0%, 15 studies, 85 
pregnancies) 
OR 2.31 ([95%CI 1.02, 5.25] 
p=0.046, I2=0.0%, 12 studies, 
184 pregnancies) 
NS NS NA 
Preterm birth NS 
74.9% ([95%CI 54.0, 103.8] 
I2=0.0%, 6 studies, 36 
pregnancies) 
43.3% ([95%CI 32.5, 57.6] 
I2=76.0%, 7 studies, 47 
pregnancies) 
OR 3.48 ([95%CI 1.17, 10.84] 
p=0.03, I2=0.0%, 6 studies, 80 
pregnancies) 
NS NA 
Neonatal death 
55.0% ([95%CI 36.4, 83.1] 
I2=0.0%, 10 studies, 47 
pregnancies) 
25.2% ([95%CI 15.9, 40.0] 
I2=0.0%, 12 studies, 76 
pregnancies) 
OR 2.84 ([95%CI 1.18, 6.77] 
p=0.019, I2=0.0%, 10 studies, 
117 pregnancies) 
NS 
34.5% ([95%CI 23.5, 50.6] 
I2=68.5%, 7 studies, 26 
pregnancies) 
25.3% ([95%CI 19.2, 33.4] 
I2=0.0%, 7 studies, 50 
pregnancies) 
OR 4.83 ([95%CI 1.14, 20.47] 
p=0.03, I2=0.0%, 6 studies, 60 
pregnancies) 
41.9% (95%CI 33.6, 52.3] 
I2=19.4%, 12 studies, 79 
pregnancies) 
11.3% (95%CI 8.6, 15.0] 
I2=24.1%, 11 studies, 49 
pregnancies) 
OR 4.95 ([95%CI 1.71, 14.30] 
p=0.003, I2=0.0%, 11 studies, 
124 pregnancies) 
 
Figure 1 Quality assessment of included studies according to ‘Strengthening The 
Reporting of Observational studies in Epidemiology’ (STROBE) checklist 
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